Recombinant Human HIF-1 alpha Protein，His

Hypoxia-inducible factor 1-alpha (HIF-1α) is a critical transcription factor that plays a pivotal role in cellular responses to low oxygen levels (hypoxia). Its importance is underscored by its involvement in various physiological processes, including angiogenesis, metabolism, and cell survival. Under normoxic conditions, HIF-1α is continuously degraded; however, in hypoxic environments, it stabilizes, translocates to the nucleus, and dimerizes with HIF-1β to activate numerous target genes essential for adapting to oxygen deficiency. Research has shown that dysregulation of HIF-1α is implicated in multiple pathological conditions, including cancer, ischemic diseases, and inflammatory disorders. Its role in promoting tumor growth and survival has made HIF-1α a prime target for therapeutic interventions, driving the interest in the development of HIF-1α recombinant proteins for both basic research and clinical applications. These recombinant proteins can be used to dissect the molecular mechanisms underlying HIF-1α function, evaluate its potential as a drug target, and explore its role in disease pathophysiology. Recent advancements in recombinant protein technology have facilitated the production and purification of functional HIF-1α proteins, enabling researchers to investigate their structure-function relationships and interactions with downstream signaling pathways. The ongoing studies on HIF-1α not only enhance our understanding of hypoxic responses but also pave the way for novel therapeutic strategies aimed at modulating its activity for disease treatment.